These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 9343241)

  • 21. Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin.
    Skehel JJ; Wiley DC
    Annu Rev Biochem; 2000; 69():531-69. PubMed ID: 10966468
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lysolipids do not inhibit influenza virus fusion by interaction with hemagglutinin.
    Baljinnyam B; Schroth-Diez B; Korte T; Herrmann A
    J Biol Chem; 2002 Jun; 277(23):20461-7. PubMed ID: 11923295
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of influenza H7 hemagglutinin-mediated entry.
    Antanasijevic A; Cheng H; Wardrop DJ; Rong L; Caffrey M
    PLoS One; 2013; 8(10):e76363. PubMed ID: 24194835
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reversible pH-dependent conformational change of reconstituted influenza hemagglutinin.
    Tatulian SA; Tamm LK
    J Mol Biol; 1996 Jul; 260(3):312-6. PubMed ID: 8757795
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Influenza virus M2 protein ion channel activity helps to maintain pandemic 2009 H1N1 virus hemagglutinin fusion competence during transport to the cell surface.
    Alvarado-Facundo E; Gao Y; Ribas-Aparicio RM; Jiménez-Alberto A; Weiss CD; Wang W
    J Virol; 2015 Feb; 89(4):1975-85. PubMed ID: 25473053
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Architecture of the influenza hemagglutinin membrane fusion site.
    Bentz J; Mittal A
    Biochim Biophys Acta; 2003 Jul; 1614(1):24-35. PubMed ID: 12873763
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Membrane fusion mechanisms: the influenza hemagglutinin paradigm and its implications for intracellular fusion.
    Stegmann T
    Traffic; 2000 Aug; 1(8):598-604. PubMed ID: 11208147
    [TBL] [Abstract][Full Text] [Related]  

  • 28. pH Optimum of Hemagglutinin-Mediated Membrane Fusion Determines Sensitivity of Influenza A Viruses to the Interferon-Induced Antiviral State and IFITMs.
    Gerlach T; Hensen L; Matrosovich T; Bergmann J; Winkler M; Peteranderl C; Klenk HD; Weber F; Herold S; Pöhlmann S; Matrosovich M
    J Virol; 2017 Jun; 91(11):. PubMed ID: 28356532
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intermonomer Interactions in Hemagglutinin Subunits HA1 and HA2 Affecting Hemagglutinin Stability and Influenza Virus Infectivity.
    Wang W; DeFeo CJ; Alvarado-Facundo E; Vassell R; Weiss CD
    J Virol; 2015 Oct; 89(20):10602-11. PubMed ID: 26269180
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Conformational changes and fusion activity of influenza virus hemagglutinin of the H2 and H3 subtypes: effects of acid pretreatment.
    Puri A; Booy FP; Doms RW; White JM; Blumenthal R
    J Virol; 1990 Aug; 64(8):3824-32. PubMed ID: 2196382
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structural intermediates in the low pH-induced transition of influenza hemagglutinin.
    Gao J; Gui M; Xiang Y
    PLoS Pathog; 2020 Nov; 16(11):e1009062. PubMed ID: 33253316
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influenza virus entry.
    Luo M
    Adv Exp Med Biol; 2012; 726():201-21. PubMed ID: 22297515
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intermonomer disulfide bonds impair the fusion activity of influenza virus hemagglutinin.
    Kemble GW; Bodian DL; Rosé J; Wilson IA; White JM
    J Virol; 1992 Aug; 66(8):4940-50. PubMed ID: 1629960
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Conformational intermediates and fusion activity of influenza virus hemagglutinin.
    Korte T; Ludwig K; Booy FP; Blumenthal R; Herrmann A
    J Virol; 1999 Jun; 73(6):4567-74. PubMed ID: 10233915
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reversible structural changes in the influenza hemagglutinin precursor at membrane fusion pH.
    Garcia-Moro E; Zhang J; Calder LJ; Brown NR; Gamblin SJ; Skehel JJ; Rosenthal PB
    Proc Natl Acad Sci U S A; 2022 Aug; 119(33):e2208011119. PubMed ID: 35939703
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Structural transitions in influenza haemagglutinin at membrane fusion pH.
    Benton DJ; Gamblin SJ; Rosenthal PB; Skehel JJ
    Nature; 2020 Jul; 583(7814):150-153. PubMed ID: 32461688
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Structure of influenza haemagglutinin at the pH of membrane fusion.
    Bullough PA; Hughson FM; Skehel JJ; Wiley DC
    Nature; 1994 Sep; 371(6492):37-43. PubMed ID: 8072525
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The kinetics of the acid-induced conformational change of influenza virus haemagglutinin can be followed using 1,1'-bis(4-anilino-5-naphthalenesulphonic acid).
    Bethell RC; Gray NM; Penn CR
    Biochem Biophys Res Commun; 1995 Jan; 206(1):355-61. PubMed ID: 7818541
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fusion mutants of the influenza virus hemagglutinin glycoprotein.
    Daniels RS; Downie JC; Hay AJ; Knossow M; Skehel JJ; Wang ML; Wiley DC
    Cell; 1985 Feb; 40(2):431-9. PubMed ID: 3967299
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Structural basis of influenza virus fusion inhibition by the antiviral drug Arbidol.
    Kadam RU; Wilson IA
    Proc Natl Acad Sci U S A; 2017 Jan; 114(2):206-214. PubMed ID: 28003465
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.